Search

Search Funnelback University

Search powered by Funnelback
61 - 80 of 111 search results for `systemic lupus erythematosus`
  1. Fully-matching results

  2. https://www.med.cam.ac.uk/smith/wp-json/wp/v2/pages/26

    https://www.med.cam.ac.uk/smith/wp-json/wp/v2/pages/26
    23 Feb 2024: Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus.” strongNephrology Dialysis Transplantation,/strong 2010;25:3586-3592. ... and Macary, P.A. “Lipid anti-lipid antibody responses correlate with
  3. Professor Menna Clatworthy FMedSci | Cambridge Immunology Network

    https://www.immunology.cam.ac.uk/Networkdirectory/mrc
    23 Feb 2024: Previously we have investigated the role of FcγRIIB in regulating the immune response to pathogens, (particularly Streptococcus pneumoniae and malaria), and in conferring susceptibility to the autoimmune disease systemic lupus erythematosus.
  4. Dr Paul Lyons | Cambridge Immunology Network

    https://www.immunology.cam.ac.uk/Networkdirectory/pal34%40cam.ac.uk
    23 Feb 2024: This is a collaboration between clinicians, basic scientists and bioinformaticians that aims to apply expression profiling to the clinical management of autoimmune diseases such as systemic lupus erythematosus and small vessel ... Jolly, EC, Watts, R, Lau
  5. Modelling of Disease - MRC Biostatistics Unit

    https://www.mrc-bsu.cam.ac.uk/blog/modelling-of-disease/
    23 Feb 2024: disease. For both psoriatic arthritis, which is an autoimmune arthritis associated with psoriasis, and for systemic lupus erythematosus, models have been developed to link the variable pattern of potentially reversible disease ... An international
  6. Dr Elaine Jolly | Cambridge Immunology Network

    https://www.immunology.cam.ac.uk/Networkdirectory/jolly
    23 Feb 2024: Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake.
  7. Dr Shaun Flint | Cambridge Immunology Network

    https://www.immunology.cam.ac.uk/Networkdirectory/shaun
    23 Feb 2024: My current research aims to identify clinically useful biomarkers in Takayasu’s Arteritis (TA) and Behçet’s disease, and examine geographic differences in Systemic Lupus Erythematosus (SLE) using as a starting
  8. Dr Alexandre Bignon | Cambridge Immunology Network

    https://www.immunology.cam.ac.uk/Networkdirectory/bignon
    23 Feb 2024: in immunology from Paris-Sud 11 University in September 2014. His PhD works focused on the expression and function of chemokine receptors in two immune disorders, namely CCR1 in the ... Expression of CXCL12 receptors in B cells from Mexican Mestizos
  9. Dr Luis F. Quintana | Cambridge Immunology Network

    https://www.immunology.cam.ac.uk/Networkdirectory/quintana
    23 Feb 2024: Search site. Cambridge Immunology Network. Dr Luis F. Quintana. Biomarker studies in ANCA-associated vasculitis, lupus and immune-mediated renal disease. ... We perform state-of-the-art proteomic analyses on plasma and urine samples of patients with
  10. Dr Marion Espéli | Cambridge Immunology Network

    https://www.immunology.cam.ac.uk/Networkdirectory/me301
    23 Feb 2024: I have recently showed that in lupus nephritis, autoreactive plasma cells mostly home and survive in the inflamed kidneys, suggesting that the renal plasma cell niche may constitute a new therapeutic ... Local renal autoantibody production in lupus
  11. Discovery and development of treatments for immunological diseases

    https://www.ubs.admin.cam.ac.uk/system/files/public/discovery_and_development_of_treatments_for_immunological_diseases_non-technical_summary_redacted.pdf
    29 Apr 2024: Why is it important to undertake this work? Despite decades of research, millions of people live with serious immune mediated disease such as colitis, arthritis, systemic lupus erythematosus (SLE) and atopic ... Although these may impact movement and
  12. SPECIAL NO. 1] LECTURE-LIST–MICHAELMAS TERM 2006 187 continued >…

    https://www.reporter.admin.cam.ac.uk/reporter/2006-07/special/01/pdfs/nat_sci_2.pdf
    25 Sep 2006: SMITHSystemic lupus erythematosus I. M. 6 Nov.Systemic lupus erythematosus II. (Lecture: 1.30–2.30pm).
  13. https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/pages/4193

    https://www2.mrc-lmb.cam.ac.uk/wp-json/wp/v2/pages/4193
  14. Dr Frances Hall | Sidney Sussex College Cambridge

    https://www.sid.cam.ac.uk/people/dr-frances-hall
    Thumbnail for Dr Frances Hall | Sidney Sussex College Cambridge Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... An audit of recording cardiovascular risk factors in patients with rheumatoid arthritis and systemic lupus erythematosus in
  15. Dr Lisa Willcocks | Cambridge Immunology Network

    https://www.immunology.cam.ac.uk/Networkdirectory/willcocks
    23 Feb 2024: Takayasu’s arteritis. Cryogobulinaemia. Henoch-Schonlein purpura. Lupus (SLE). Behcet’s disease. Autoimmune deafness. ... A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus
  16. PhenoScanner

    www.phenoscanner.medschl.cam.ac.uk/studies/
    Systemic lupus erythematosus. ... Systemic lupus erythematosus. 3094. 489836.
  17. A promoter-level mammalian expression atlas

    https://supfam.mrc-lmb.cam.ac.uk/bioinformatics/people/julian_gough/publications/forrest_nature_2014.pdf
    19 Mar 2014: Systemic lupus erythematosus (K)Chromosome maintenance (R)IL-2 down reg. targets (N)Transcription (R).
  18. https://www.citiid.cam.ac.uk/wp-json/wp/v2/pages/6779

    https://www.citiid.cam.ac.uk/wp-json/wp/v2/pages/6779
    to Lead Developments in Immune-Mediated Disease/h1npCITIID is already driving therapeutic breakthroughs in immune-mediated disease such as inflammatory bowel disease and systemic lupus erythematosus.
  19. Professor David Jayne - Experimental Medicine and Immunotherapeutics…

    https://emit.medschl.cam.ac.uk/people/investigators/dr-david-jayne/
    23 Feb 2024: Professor of Clinical Autoimmunity, University of Cambridge. Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital. ... Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission,
  20. Alex Hatton | Cambridge Immunology Network

    https://www.immunology.cam.ac.uk/Networkdirectory/ah483%40cam.ac.uk
    23 Feb 2024: Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis.
  21. Human Antibodies developed for Treatment of Lupus and Anthrax - MRC…

    https://www2.mrc-lmb.cam.ac.uk/human-antibodies-developed-for-treatment-of-lupus-and-anthrax/
    Thumbnail for Human Antibodies developed for Treatment of Lupus and Anthrax - MRC Laboratory of Molecular Biology 31 Jul 2009: Systemic lupus erythematosus is a chronic, life-threatening inflammatory autoimmune disease, caused by multiple genetic, environmental, and other factors, most of which are unknown. ... Approximately five million people worldwide, including about 1.5

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.